United Therapeutics Corporation · NASDAQ:UTHR

Rothblatt Martine A sold 9,500 United Therapeutics Corporation shares (Form 4)

Traded Sep 9, 2026 · Filed Sep 10, 2026

On Sep 9, 2026, Rothblatt Martine A (Director, Chairperson & CEO) sold 9,500 United Therapeutics Corporation shares at an average US$501.84 for US$4.77M under a trading plan, leaving 324,443 shares. Filed Sep 10, 2026 (Form 4).

Sold
9,500 shares
Price
US$501.84 average (US$493.81 to US$509.00)
Value
US$4.77M
Holding after
324,443 shares (held indirectly)
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chairperson & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Sep 9, 2026Common StockOption exercise9,500US$117.76333,943Indirect
Sep 9, 2026Common StockSale80US$493.81333,863Indirect
Sep 9, 2026Common StockSale1,202US$495.65332,661Indirect
Sep 9, 2026Common StockSale1,278US$496.73331,383Indirect
Sep 9, 2026Common StockSale160US$497.56331,223Indirect
Sep 9, 2026Common StockSale400US$498.85330,823Indirect
Sep 9, 2026Common StockSale519US$499.73330,304Indirect
Sep 9, 2026Common StockSale361US$500.84329,943Indirect
Sep 9, 2026Common StockSale1,017US$502.87328,926Indirect
Sep 9, 2026Common StockSale1,144US$503.60327,782Indirect
Sep 9, 2026Common StockSale964US$505.03326,818Indirect
Sep 9, 2026Common StockSale875US$505.78325,943Indirect
Sep 9, 2026Common StockSale794US$506.84325,149Indirect
Sep 9, 2026Common StockSale506US$507.68324,643Indirect
Sep 9, 2026Common StockSale200US$509.00324,443Indirect

Source

View original at SEC

Related